MPLT

Conviction 100HealthcareScan · Thu, Jun 25, 2026

MPLT$32.00+4.40%

ResistanceSupportVol 14Insider sell

Vol MA14 469.4K

Mar 26Apr 14May 1May 19Jun 8Jun 25

MapLight Therapeutics, Inc.Biotechnologywww.maplightrx.com ↗

Price32.00

Change+4.40%

Gap+2.04%

Rel volume2.91×

Avg volume441.17K

Avg $ vol12.96M

SMA 2029.08

SMA 5029.15

SMA 200—

Price vs 50+9.78%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 24.56

RSI (14)59

MACD hist0.24

MACD crossbull · 1d

Stoch %K / %D95 / 76

ADX (14)18

+DI / −DI24 / 10

RSI divergenceBearish

MACD divergence—

ATR %+7.34%

ADR %8.21%

52w high32.13

52w low12.81

From 52w high-0.40%

Above 52w low+149.80%

New 52w highYes

SqueezeOn · 23d

Bollinger width16.47%

%B1.11

Donchian pos96.21%

Donchian high32.25

Donchian low25.66

AVWAP (52w high)29.33

vs AVWAP high+9.09%

AVWAP (52w low)23.36

vs AVWAP low+36.97%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d2.91×

Avg vol (14d)469.4K

Avg vol (20d)441.17K

Avg $ vol (20d)12.96M

Market cap1.36B

RS 3m (vs SPY)+68.25%

RS 6m (vs SPY)+41.41%

RS line new highNo

Trend template—

Technical rank89.6

1 week+9.55%

1 month+8.62%

3 months+76.41%

6 months+66.84%

1 year—

YTD+90.82%

P/E-8.43

P/B3.40

P/S—

P/FCF-9.80

EPS-18.56

Div yield—

ROE-40.30%

ROA-38.48%

Debt/Eq—

Current22.91

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-107.72%

Price target41.22

Target upside28.81%

Analyst ratingBuy

Institutional60.21%

Ent. value1.3B

Revenue—

Net income-60.67M

Gross profit—

Free cash flow-138.61M

IndustryBiotechnology

ExchangeNasdaq

Shares out42.62M

Employees133

ListedMon, Oct 27, 2025

Free float18.66M

Float %41.1%

Short interest1.56M

Days to cover5.4d

Short volume72.5%

Squeeze score77 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.34 vs −$0.91

Last surprise-47.3% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank89.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance31.38

Support25.44

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MPLT

All disclosures →

No recent disclosed trades by Congress in MPLT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MPLT · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Babler Martin Director · Stock Option (right to buy) · 2026-06-23	Grant	29.8K	—	2026-06-23	2026-06-25
Garnett Timothy John Director · Voting Common Stock · 2026-06-23	Grant	3.93K	—	2026-06-23	2026-06-25
Garnett Timothy John Director · Stock Option (right to buy) · 2026-06-23	Grant	14.9K	—	2026-06-23	2026-06-25
Cox Troy Director · Stock Option (right to buy) · 2026-06-23	Grant	29.8K	—	2026-06-23	2026-06-25
Babler Martin Director · Voting Common Stock · 2026-06-23	Grant	7.86K	—	2026-06-23	2026-06-25
Cox Troy Director · Voting Common Stock · 2026-06-23	Grant	7.86K	—	2026-06-23	2026-06-25
Luneborg Nanna Liebach Director · Voting Common Stock · 2026-06-23	Grant	3.93K	—	2026-06-23	2026-06-25
Luneborg Nanna Liebach Director · Stock Option (right to buy) · 2026-06-23	Grant	14.9K	—	2026-06-23	2026-06-25
Pavlov George Director · Voting Common Stock · 2026-06-23	Grant	3.93K	—	2026-06-23	2026-06-25
Pavlov George Director · Stock Option (right to buy) · 2026-06-23	Grant	14.9K	—	2026-06-23	2026-06-25

SEC filings

EDGAR filings in MPLT · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.